EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 21 / No 8-9 (Août–Septembre 2005) Med Sci (Paris), 21 8-9 (2005) 741-746 References
Free Access
Issue
Med Sci (Paris)
Volume 21, Number 8-9, Août–Septembre 2005
Page(s) 741 - 746
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005218-9741
Published online 15 August 2005
  1. O’Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136 : 355–60. [Google Scholar]
  2. Devic E, Rizzoti K, Bodin S, et al. Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 1999; 84 : 199–203. [Google Scholar]
  3. O’Carroll A, Selby TL, Palkovits M, et al. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 2000; 1492 : 72–80. [Google Scholar]
  4. De Mota N, Lenkei Z, Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 2000; 72 : 400–7. [Google Scholar]
  5. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251 : 471–6. [Google Scholar]
  6. Habata Y, Fujii R, Hosoya M, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999; 13 : 25–35. [Google Scholar]
  7. Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000; 74 : 34–41. [Google Scholar]
  8. De Mota N, Reaux-Le Goazigo A, El Messari S, et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 2004; 101 : 10464–9. [Google Scholar]
  9. Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin : tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538 : 162–71. [Google Scholar]
  10. Zou MX, Liu HY, Haraguchi Y, et al. Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Lett 2000; 473 : 15–8. [Google Scholar]
  11. Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003; 84 : 1162–72. [Google Scholar]
  12. Reaux A, De Mota N, Skultetyova I, et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001; 77 :1085–96. [Google Scholar]
  13. El Messari S, Iturrioz X, Fassot C, et al. Functional dissociation of apelin receptor signaling and endocytosis : implications for the effects of apelin on arterial blood pressure. J Neurochem 2004; 90 : 1290–301. [Google Scholar]
  14. Masri B, Morin N, Cornu M, et al. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 2004; 18 : 1909–11. [Google Scholar]
  15. Reaux A, Gallatz K, Palkovits M, Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 2002; 113 : 653–62. [Google Scholar]
  16. Brailoiu, GC, Dun SL, Yang J, et al. Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett 2002; 327 : 193–7. [Google Scholar]
  17. Reaux-Le Goazigo A, Morinville A, Burlet A, et al. Dehydration-induced cross regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 2004; 145 : 4392–400. [Google Scholar]
  18. Johnson AK, Cunningham JT, Thunhorst RL. Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clin Exp Pharmacol Physiol 1996; 23 : 183–91. [Google Scholar]
  19. O’Carroll AM, Lolait SJ. Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraoptic nuclei by osmotic stimuli. J Neuroendocrinol 2003; 15 : 661–6. [Google Scholar]
  20. Hurbin A, Boissin-Agasse L, Orcel H, et al. The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons. Endocrinology 1998; 139 : 4701–7. [Google Scholar]
  21. Brownstein MJ, Russell JT, Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 1980; 207 : 373–8. [Google Scholar]
  22. Manning M, Lowbridge J, Haldar J, et al. Design of neurohypophyseal peptides that exhibit selective agonistic and antagonistic properties. Fed Proc 1977; 36 : 1848–52. [Google Scholar]
  23. Zini S, Fournie-Zaluski MC, Chauvel E, et al. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors : predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 1996; 93 : 11968–73. [Google Scholar]
  24. Gutkowska J, Antunes-Rodrigues J, McCann SM. Atrial natriuretic peptide in brain and pituitary gland. Physiol Rev 1997; 77 : 465–515. [Google Scholar]
  25. Poulain DA, Wakerley JB, Dyball RE. Electrophysiological differentiation of oxytocin- and vasopressin-secreting neurones. Proc R Soc Lond B Biol Sci 1977; 196 : 367–84. [Google Scholar]
  26. Gouzenes L, Desarmenien MG, Hussy N, et al. Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons. J Neurosci 1998; 18 : 1879–85. [Google Scholar]
  27. Ludwig M. Dendritic release of vasopressin and oxytocin. J Neuroendocrinol 1998; 10 : 881–95. [Google Scholar]
  28. Hosoya M, Kawamata Y, Fukusumi S et al. Molecular and functional characteristics of APJ : tissue distribution of mRNA and interaction with endogenous ligand, apelin. J Biol Chem 2000; 275 : 21061–7. [Google Scholar]
  29. De Falco M, De Luca L, Onori N, et al. Apelin expression in normal human tissues. In Vivo 2002; 16 : 333–6. [Google Scholar]
  30. Denton DA, McKinley MJ, Weisinger RS. Hypothalamic integration of body fluid regulation. Proc Natl Acad Sci USA 1996; 93 : 7397–404. [Google Scholar]
  31. Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99 : 87–92. [Google Scholar]
  32. Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002; 91 : 434–40. [Google Scholar]
  33. Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003; 108 : 1432–9. [Google Scholar]
  34. Berry MF, Pirolli TJ, Jayasankar V, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004; 110 : II187–93. [Google Scholar]
  35. Ashley EA, Powers J, Chen M, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovascular Res 2005; 65 :73–82. [Google Scholar]
  36. Földes G, Horkay F, Szokodi I, et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003; 308 : 480–5. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.